NYXOAH
91.66
EUR
(-1.63%)
03/21/2025 - 16:34
Closed 15 min delayed data - Euronext Bruxelles
| Open: | 92.60 |
| Change: | -1.52 |
| Volume: | 555,546 |
| Low: | 91.20 |
| High: | 92.74 |
| High / Low range: | 1.54 |
| Type: | Stocks |
| Ticker: | NYXH |
| ISIN: | BE0974358906 |
NYXOAH news, videos and press releases
For more news please use our advanced search feature.
NYXOAH - More news...
NYXOAH - More news...
- 03/13/2025 - 06:00 EQS-News: Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results
- 03/03/2025 - 21:30 Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
- 02/19/2025 - 06:05 EQS-News: Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East
- 01/20/2025 - 21:30 Publication relating to transparency notifications
- 12/13/2024 - 07:05 EQS-News: Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England
- 11/27/2024 - 21:30 Information on the total number of voting rights and shares
- 11/20/2024 - 21:05 Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
- 11/19/2024 - 06:00 Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024
- 11/18/2024 - 21:30 Publication relating to transparency notifications
- 11/06/2024 - 21:05 EQS-News: Nyxoah Reports Third Quarter Financial and Operating Results
- 11/04/2024 - 21:45 Nyxoah Appoints John Landry as Chief Financial Officer
- 10/25/2024 - 20:30 Publication relating to transparency notifications
- 10/22/2024 - 20:30 Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024
- 10/09/2024 - 20:30 Publication relating to transparency notifications
- 10/08/2024 - 12:00 EQS-News: Nyxoah Raises $27 Million through its At-the-Market Offering
- 10/07/2024 - 21:00 Nyxoah Raises $27 Million through its At-the-Market Offering
- 09/27/2024 - 20:30 EQS-News: DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
- 09/27/2024 - 06:05 Information on the total number of voting rights and shares
- 09/02/2024 - 20:05 EQS-News: Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
- 09/02/2024 - 20:05 Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
- 08/06/2024 - 20:05 EQS-News: Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results
- 07/15/2024 - 06:15 EQS-News: Nyxoah Appoints Scott Holstine as Chief Commercial Officer
- 07/03/2024 - 10:30 EQS-News: Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank
- 07/01/2024 - 06:00 Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA
- 06/28/2024 - 20:30 Information on the total number of voting rights and shares
- 06/03/2024 - 20:15 Information on the total number of voting rights and shares
- 06/03/2024 - 20:05 Publication relating to transparency notifications
- 05/31/2024 - 06:00 Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
- 05/28/2024 - 20:30 Information on the Total Number of Voting Rights and Shares
- 05/23/2024 - 13:59 Nyxoah Announces Pricing of Offering
